Nanocarriers are promising in tumour-targeting drug delivery but limited by their delivery efficiency within tumour microenvironment (TME). Here the authors report the development of lipoic acid ...

Bunge Global SA (NYSE: BG) today reported fourth quarter and full-year 2024 results. Full-year GAAP diluted EPS of $7.99 vs. $14.87 in the prior year; $9.19 vs. $13.66 ...